San Jose, CA-based startup Evident Vascular has secured $35 million in Series A funding from Vensana Capital to develop an AI-enabled intravascular ultrasound (IVUS) platform.
The platform's development will focus on applications for the treatment of peripheral vascular disease, a slow and progressive circulation disorder that affects the legs and feet.
"Robust clinical trial data supporting utilization in both coronary and peripheral interventions are fueling future market growth," the company said.
